NCT06258538 Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke
| NCT ID | NCT06258538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Stroke Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 87 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 87 participants in total. It began in 2024-06-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study proposes a novel stroke rehabilitation approach for upper extremity training by firstly combining different types of distal robot-assisted and task-oriented therapy in a circuit training program. The program could enhance UE functions, improving daily function, decrease caregiver burden and lower medical expenses associated with long-term care. Professionals can use these findings to promote the application of clinically empirical research and better understand the effects and mechanisms of circuit training.
Eligibility Criteria
Inclusion Criteria: 1. unilateral stroke ≥ 3 months onset 2. Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score between 18 to 56, indicating different levels of motor impairments ; 3. without excessive spasticity in any of the UE joint (modified Ashworth scale ≤3 in proximal joints and modified Ashworth scale ≤2 in distal joints); 4. Mini Mental State Exam (MMSE) score \> 24, indicating no serious cognitive impairment; 5. between the ages of 20 and 75 years - Exclusion Criteria: 1. histories of other neurological diseases such as dementia, Parkinson's disease, and peripheral polyneuropathy; 2. difficulties in following and understanding instructions such as global aphasia; 3. enroll in other rehabilitation or drug studies simultaneously; 4. receiving Botulinum toxin injections within 3 months. -
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06258538 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 75 Years, studying Stroke Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06258538 currently recruiting?
Yes, NCT06258538 is actively recruiting participants. Contact the research team at ywhlab.ra@gmail.com for enrollment information.
Where is the NCT06258538 trial being conducted?
This trial is being conducted at Taoyuan, Taiwan.
Who is sponsoring the NCT06258538 clinical trial?
NCT06258538 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 87 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.